Home
Clinical Resources Search
PQI: Medication Induced Hand-Foot Syndrome

Medication Induced Hand-Foot Syndrome

Download PQI pdf 0.19MB

Last Updated: September 22, 2023

By: Jonas Congelli, RPh

About this PQI

The goal of this PQI is to discuss prevention and management of Hand-Foot Syndrome.

More About This PQI

PQI:

Managing-TKI-Induced-Hand-Foot-Skin-Reaction_PQI_NCODA pdf 0.18MB

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

Medication Induced Hand-Foot Syndrome

About this PQI

More About This PQI

PQI:

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia

PQI: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC

PQI in Action: Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

PQI in Action: Nirogacestat (OGSIVEO®) use in Management of Adults with Progressing Desmoid Tumors (or fibromatosis or aggressive fibromatosis)

PQI in Action: Abiraterone acetate (Yonsa®) Patient Selection and Management

PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma

S9 E7: A Haven of Healing

S9 E6: Healing Through Sound: A Breast Cancer Journey

S9 E5: Global Health, Cancer Survivorship, and Advancing Equity

S9 E4: Advancing Pharmacogenomics in Oncology

Readiness Tracker

Treatment Support Kit: Elranatamab

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Understanding and Managing Treatment-Related Hand-Foot Syndrome/Hand-Foot Skin Reaction

PQI: Managing TKI-Induced Hand-Foot Skin Reaction

Understanding and Managing Treatment-Related Hand-Foot Syndrome/Hand-Foot Skin Reaction

PQI: Managing TKI-Induced Hand-Foot Skin Reaction

Cabozantinib

Treatment Support Kit: Cabozantinib

PQI: Cabozantinib (Cabometyx®)

Cabozantinib

Treatment Support Kit: Cabozantinib

PQI: Cabozantinib (Cabometyx®)

Capecitabine and Mitomycin with Radiation Therapy

Tislelizumab, Capecitabine, and Cisplatin

Pembrolizumab, Capecitabine, and Cisplatin

Tislelizumab and CAPOX

Sorafenib

PQI: Sorafenib (Nexavar®) for the Treatment of Hepatocellular Carcinoma and Transition to Second-line Regorafenib (Stivarga®)

Regorafenib

PQI: Sorafenib (Nexavar®) for the Treatment of Hepatocellular Carcinoma and Transition to Second-line Regorafenib (Stivarga®)

PQI: Regorafenib (Stivarga®) in the Treatment of Hepatocellular Carcinoma

PQI: Regorafenib (Stivarga®) in Metastatic Colorectal Cancer

Sorafenib

PQI: Sorafenib (Nexavar®) for the Treatment of Hepatocellular Carcinoma and Transition to Second-line Regorafenib (Stivarga®)

Regorafenib

PQI: Sorafenib (Nexavar®) for the Treatment of Hepatocellular Carcinoma and Transition to Second-line Regorafenib (Stivarga®)

PQI: Regorafenib (Stivarga®) in the Treatment of Hepatocellular Carcinoma

PQI: Regorafenib (Stivarga®) in Metastatic Colorectal Cancer

How to Categorize Cancer Drug Therapy

PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia

PQI: Bone Health and the Cancer Patient

The PQI Podcast S4 Ep 5: Role of Oncology Social Worker

Capecitabine and Mitomycin with Radiation Therapy

Tislelizumab, Capecitabine, and Cisplatin

Pembrolizumab, Capecitabine, and Cisplatin

Tislelizumab and CAPOX

Bortezomib

Capecitabine and Mitomycin with Radiation Therapy

Fluorouracil and Mitomycin with Radiation Therapy

Bortezomib and Dexamethasone